Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model
Alzheimer's & Dementia · 2024-04 · 20 (4) · 2397-2407
DOI: 10.1002/alz.13699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024-02. Verfasst von Samantha M Rossano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York,…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Evidence suggests microglial activation precedes regional tau and neurodegeneration in Alzheimer's disease (AD). We characterized microglia with translocator protein (TSPO) positron emission tomography (PET) within an AD progression model where global amyloid beta (Aβ) precedes local tau and neurodegeneration, resulting in cognitive impairment. METHODS Florbetaben, PBR28, and MK‐6240 PET, T1 magnetic resonance imaging, and cognitive measures were performed in 19 cognitively unimpaired older adults and 22 patients with mild cognitive impairment or mild AD to examine associations among microglia activation, Aβ, tau, and cognition, adjusting for neurodegeneration. Mediation analyses evaluated the possible role of microglial activation along the AD progression model. RESULTS Higher PBR28 uptake was associated with higher Aβ, higher tau, and lower MMSE score, independent of neurodegeneration. PBR28 mediated associations between tau in early and middle Braak stages, between tau and neurodegeneration, and between neurodegeneration and cognition. DISCUSSION Microglia are associated with AD pathology and cognition and may mediate relationships between subsequent steps in AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Anesthesiology and Perioperative Medicine, University of California Los Angeles Health, Los Angeles, California, USA.
- Department of Psychiatry and Biostatistics, Columbia University Irving Medical Center, New York, New York, USA.
ORCID-Profile: Samantha M Rossano, Patrick Lao
Förderung
- NIA NIH HHS
Zitieren
APA
Rossano, S. M., Johnson, A. S., Smith, A., Ziaggi, G., Roetman, A., Guzman, D., Okafor, A., Klein, J., Tomljanovic, Z., Stern, Y., Brickman, A. M., Lee, S., Kreisl, W. C., & Lao, P. (2024). Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model. Alzheimer's & Dementia, 20(4), 2397-2407. https://doi.org/10.1002/alz.13699
Vancouver
Rossano SM, Johnson AS, Smith A, Ziaggi G, Roetman A, Guzman D, et al. Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model. Alzheimer's & Dementia. 2024;20(4):2397-2407. doi:10.1002/alz.13699
BibTeX
@article{Rossano2024,
author = {Rossano, Samantha M and Johnson, Aubrey S and Smith, Anna and Ziaggi, Galen and Roetman, Andrew and Guzman, Diana and Okafor, Amarachukwu and Klein, Julia and Tomljanovic, Zeljko and Stern, Yaakov and Brickman, Adam M and Lee, Seonjoo and Kreisl, William C and Lao, Patrick},
title = {Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {4},
pages = {2397--2407},
doi = {10.1002/alz.13699}
}
EUVIMED